Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2015

Sep 30, 2015

33090_dirs_2015-09-30_520781b2-4741-4689-8626-35822e686a1c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2015-09-30

Reporting Person: Pinney Jack T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-30 Common Stock A 6250 Acquired 770829 Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the Director Compensation Plan.